Table 3

Cox regression models of NCS for both overall survival (OS) and disease-free survival (DFS) in Italian and Japanese cohorts

CohortSurvivalLog-rank testLikelihood ratio testHR95% CIConfounders
ItalianOS4.52e-086.63e-060.313(0.189 to 0.518)AlphaFP, CHILD, multinodularity
ItalianDFS0.02610.2850.791(0.515 to 1.22)Multinodularity
JapaneseOS0.00910.02030.544(0.325 to 0.91)Age
JapaneseDFS0.008370.07780.704(0.476 to 1.04)BCLC
  • The models are evaluated in terms of: (1) p-value from log-rank test assessing the fit performance of the whole model including both NCS and confounders; (2) p-value from likelihood ratio test assessing the statistical significance of the specific coefficient estimated for NCS in the model, used to derive the corresponding HR with the related 95% CI. The confounders reported in the last column are those selected for the final model after the step-down selection procedure described in the Materials and methods section.

  • AlphaFP, alpha-fetoprotein tumor marker; BCLC, Barcelona Clinic Liver Cancer Staging System; CHILD, Child-Pugh Staging System; NCS, necroptosis core score.